Published in Vaccine Weekly, April 7th, 2004
"Whole bacteriophage lambda particles, containing reporter genes under the control of the cytomegalovirus promoter (PCMV ), have been used as delivery vehicles for nucleic acid immunization. Following intramuscular injection of mice with lambda-gt11 containing the gene for hepatitis B surface antigen (HBsAg), anti-HBsAg responses in excess of 150 mIU/mL were detected. When isolated peritoneal macrophages were incubated with whole lambda particles containing the gene for green fluorescent protein (GFP) under the control of PCMV , GFP antigen was detected on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-04-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.